BPC 157 Dosing (Common Protocols), Oral Subcutaneous, 500 mcg daily, Duration: 6 weeks, Intramuscular Peritendinous, 1 mg daily, Duration: 6 weeks, Note:, Not approved by FDA or BPC 157: Interesting Biology, Limited Clinical Proof, BPC 157 is biologically interesting, but its not clinically proven. Most evidence is preclinical, and human data is still small and preliminary. BPC 157 Injection Dosage and Benefits for Chronic Pain Relief Peptide Therapy for Pain Management and Healing Core Medical & Wellness